oleanolic acid has been researched along with Experimental Mammary Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Han, Y; Qiao, W; Wang, J; Yang, X; Zhao, H | 1 |
| Cheng, J; Han, Y; Wang, J; Yang, X; Zhao, H | 1 |
| Bhatia, D; Bishayee, A; Darvesh, AS; Mandal, A; Thoppil, RJ | 1 |
| Bhatia, D; Bishayee, A; Mandal, A | 1 |
| Clapper, ML; Grubbs, CJ; Juliana, MM; Lubet, RA; McCormick, DL; Steele, VE; Townsend, R | 1 |
| Albini, A; Gribble, GW; Honda, T; Lamph, WW; Liby, K; Risingsong, R; Royce, DB; Sogno, I; Sporn, MB; Vannini, N; Williams, CR; Yore, MM | 1 |
| Liby, K; Risingsong, R; Royce, D; Sporn, MB; Tran, K; Williams, CR | 1 |
| Andreeff, M; Dietrich, M; Konopleva, M; Ling, X; Madden, TL; McQueen, T; Ruvolo, V; Schober, W; Stephens, LC; Zeng, Z | 1 |
8 other study(ies) available for oleanolic acid and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Nanomedicine-Cum-Carrier by Co-Assembly of Natural Small Products for Synergistic Enhanced Antitumor with Tissues Protective Actions.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Products; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Glycyrrhetinic Acid; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Conformation; Nanomedicine; Nanoparticles; Oleanolic Acid; Paclitaxel; Particle Size; Stereoisomerism; Surface Properties | 2020 |
Bioactive Natural Small Molecule-Tuned Coassembly of Photosensitive Drugs for Highly Efficient Synergistic and Enhanced Type I Photochemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorophyllides; Density Functional Theory; Drug Carriers; Drug Screening Assays, Antitumor; Humans; Injections, Intravenous; Mammary Neoplasms, Experimental; Mice; Molecular Dynamics Simulation; Molecular Structure; Oleanolic Acid; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Surface Properties | 2020 |
Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Oleanolic Acid; Rats; Rats, Sprague-Dawley | 2013 |
Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Proliferation; Chemoprevention; Cyclooxygenase 2; Down-Regulation; Female; HSP90 Heat-Shock Proteins; I-kappa B Proteins; Inflammation; Mammary Neoplasms, Experimental; NF-kappa B; NF-KappaB Inhibitor alpha; Oleanolic Acid; Rats; Rats, Sprague-Dawley | 2014 |
5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?
Topics: Activation, Metabolic; Animals; Antineoplastic Agents; Antioxidant Response Elements; Carcinogens; Disease Progression; Female; Imidazoles; Intestinal Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Tongue Neoplasms | 2016 |
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Drug Synergism; Endothelial Cells; Female; Humans; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Neovascularization, Pathologic; Nicotinic Acids; Oleanolic Acid; Receptor, ErbB-2; Receptors, Estrogen; Tetrahydronaphthalenes | 2008 |
The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice.
Topics: Animals; Anticarcinogenic Agents; Antigens, Polyomavirus Transforming; Carcinoma; Cell Transformation, Neoplastic; Cells, Cultured; Drug Evaluation, Preclinical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Oleanolic Acid; Receptors, Estrogen; Time Factors; Triterpenes | 2012 |
The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.
Topics: Animals; Apoptosis; Cell Growth Processes; Dendritic Cells; Female; Genetic Vectors; Lentivirus; Luciferases, Renilla; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Oleanolic Acid; Signal Transduction; Spleen; STAT3 Transcription Factor | 2007 |